News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Telo Genomics Announces Appointment of John Price as Chief Financial Officer
January 29, 2026
·
2 min read
Press Releases
Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement
January 28, 2026
·
5 min read
Press Releases
Scryb Reports Fiscal 2025 Results; Strengthened Balance Sheet and Significant Cybeats Exposure
January 28, 2026
·
4 min read
Press Releases
Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline
January 28, 2026
·
5 min read
Press Releases
Retinal Disease Expert Dr. Taiji Sakamoto Joins Kiora Pharmaceuticals’ Scientific Advisory Board
January 27, 2026
·
1 min read
Press Releases
Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference
January 26, 2026
·
4 min read
Press Releases
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules
January 26, 2026
·
1 min read
Press Releases
TempraMed Launches New Product “VIVI Med(TM),” Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
January 23, 2026
·
6 min read
Press Releases
MustGrow Closes $2.0 Million Non-Brokered LIFE Offering
January 23, 2026
·
5 min read
Press Releases
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
January 23, 2026
·
6 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us